Trials / Conditions / Complicated Urinary Tract Infections

Complicated Urinary Tract Infections

4 registered clinical trials studyying Complicated Urinary Tract Infections.

Status	Trial	Sponsor	Phase
Withdrawn	LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Urinary Tract Infection (cU NCT03377426	Novartis Pharmaceuticals	Phase 2
Completed	Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Ad NCT03357614	Iterum Therapeutics, International Limited	Phase 3
Completed	Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tra NCT03032510	Tetraphase Pharmaceuticals, Inc	Phase 3
Completed	Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefe NCT02497781	Pfizer	Phase 2